Middelfart, Denmark

Helge Thisgaard


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Helge Thisgaard

Introduction

Helge Thisgaard, an inventive mind located in Middelfart, Denmark, is recognized for his groundbreaking contributions to medical technology. His work focuses on innovative approaches to treating complex medical conditions, particularly high-grade glioma, a challenging type of brain tumor.

Latest Patents

Helge holds a notable patent related to "Auger electron therapy for glioblastoma." This patent presents a method for treating or ameliorating high-grade gliomas. It involves the intracerebral administration of a radioactive agent characterized by short-range cytotoxic ionizing radiation delivered through convection-enhanced delivery. This innovative method promises to offer new hope to patients suffering from this aggressive form of cancer.

Career Highlights

Throughout his career, Helge Thisgaard has worked with reputable institutions including Syddansk Universitet and Region Syddanmark. His experience within these organizations has enabled him to collaborate with leading professionals in the field, significantly enhancing the scope of his research and inventions.

Collaborations

Helge's work has benefitted greatly from his collaborations with esteemed colleagues such as Bo Halle and Poul Flemming Høilund-Carlsen. These partnerships have been instrumental in furthering research initiatives and refining innovative therapies in the realm of cancer treatment.

Conclusion

Helge Thisgaard stands out as an inventor dedicated to advancing medical treatments through innovation. His patent in Auger electron therapy marks a significant step forward in addressing the challenges posed by glioblastoma. As he continues to collaborate and develop new techniques, Helge's contributions are poised to make a lasting impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…